Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Paronychia
ADR ID BADD_A03312
ADR Hierarchy
11      Infections and infestations
11.02      Bacterial infectious disorders
11.02.01      Bacterial infections NEC
11.02.01.054      Paronychia
23      Skin and subcutaneous tissue disorders
23.11      Skin and subcutaneous tissue infections and infestations NEC
23.11.04      Skin and subcutaneous tissue infections NEC
23.11.04.006      Paronychia
Description A disorder characterized by an infectious process involving the soft tissues around the nail. [CTCAE] An inflammatory reaction involving the folds of the skin surrounding the fingernail. It is characterized by acute or chronic purulent, tender, and painful swellings of the tissues around the nail, caused by an abscess of the nail fold. The pathogenic yeast causing paronychia is most frequently Candida albicans. Saprophytic fungi may also be involved. The causative bacteria are usually Staphylococcus, Pseudomonas aeruginosa, or Streptococcus. (Andrews' Diseases of the Skin, 8th ed, p271) [MeSH]
MedDRA Code 10034016
MeSH ID D010304
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Felon | Infected ingrowing toe nail | Infection ingrowing toenail | Onychia | Onychia and paronychia of finger | Onychia and paronychia of toe | Paronychia | Panaritium | Whitlow | Perionychitis | Nail fold infection | Panaritium tendinosum | Perionyxis | Pandactilitis | Periungual infection | Periungual abscess | Purulent paronychia | Paronychias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00036Acitretin--
BADD_D00047Afatinib--
BADD_D00422Cetuximab--
BADD_D00424Cevimeline--
BADD_D00425Cevimeline hydrochloride--
BADD_D00566Dabrafenib--
BADD_D00567Dabrafenib mesylate--
BADD_D00750Efinaconazole--
BADD_D00800Erlotinib--
BADD_D01008Gefitinib--
BADD_D01150Indinavir--
BADD_D01151Indinavir sulfate--
BADD_D01213Isotretinoin--
BADD_D01248Lapatinib--
BADD_D01418Methotrexate--
BADD_D01543Necitumumab--
BADD_D01666Panitumumab--
BADD_D01744Pertuzumab--
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D02031Sitaxentan--
BADD_D02119Tavaborole--
BADD_D02257Trametinib--
BADD_D02258Trametinib dimethyl sulfoxide--
The 1th Page    1    Total 1 Pages